News
Cognoscienti

Barriers to Implementation of Precision Medicine for Cancer Treatment in the U.S. Healthcare System.

Cancer is a complex disease caused by a combination of genetic factors and environmental and life style influences. These manifest across a wide spectrum of...

News
Cognoscienti

Biobanking for Personalized, Precision Medicine: an Annotated Bibliography

A biobank is an organization that acquires and stores human tissue and genetic data for future research use. Biobanks provide an opportunity for more efficient...

News
Cognoscienti

Assessing Direct-to-Consumer and Consumer-Directed Products for Clinical Integration.

With more and more Direct-to-Consumer (DTC) and Consumer-Directed (CD) ‘Omics products hitting the US market, leading providers, physician groups and healthcare systems in the field...

News
Cognoscienti

Call to Action: Breaking Down Barriers for Patient Participation in Oncology Clinical Trials

A cancer diagnosis is a life-changing event. For advanced cancer in particular, standard of care treatments have limited impact on long term patient survival. Precision Medicine...

News
Cognoscienti

Precision Medicine as a New Paradigm in Drug Development

Over 2000 years ago, Hippocrates and the ancient Greeks believed that humors (bodily fluids) determined an individual’s behavior and disposition (On the Nature of...

News
Field Notes

Liquid Biopsies Bleed Into Clinical Use

Technologies that can detect cancer in circulating blood have proliferated over the past few years, but proof of their prowess in the clinic has been...

News
Field Notes

Companion Diagnostics – a Burgeoning Market

Since the first drug requiring a companion diagnostic test was approved by the U.S. Food and Drug Administration (FDA) in 1998, the global market for companion...

News
Field Notes

The Race To Collect Genomes

In April, the precision medicine field got what researchers hope is a shot of adrenaline with the announcement by AstraZeneca that it will sequence the genomes...

News
20/20

Glimcher Brings Bold, Unflinching Style to New Role as Head of Dana-Farber

Glimcher has a trail of impressive accolades that span her career as a prominent immunologist and leader. As dean of Weill Cornell Medicine, she led the recruitment...

News
SNPshot

The Rise of the Consortium: A Game Changing Approach to Dementia Research.

Cancer research is overflowing with examples of fresh approaches accelerating meaningful, patient-centered results, but it should not be the isolated example. Many other areas of research...